← Evidence map

ReviewDrug design, development and therapy2022

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights.

Maya R Chilbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35832642